News

BioNeutra Agrees to Purchase Canadian Manufacturing Facility

EDMONTON, Alberta, November 27, 2015 – BioNeutra Global Corporation (CSE: BGA) (“BioNeutra” or the “Company“) is pleased to announce that it has entered into an agreement to acquire from the vendor a building of approximately 47,000 square feet comprised of manufacturing and office space situated on 2.65 acres of land in a light industrial area of Edmonton, Alberta, Canada (the “Property”).

Regarding BioNeutra’s purchase of the Property, Dr. Jianhua Zhu, President and CEO of BioNeutra states “BioNeutra is proud and excited to add Canadian manufacturing capacity to its production portfolio. This purchase represents a significant step in diversifying our manufacturing capabilities and will expose our brands to a wider base of customers.”

Further information about BioNeutra is available under its profile on the SEDAR website www.sedar.com and on the CSE website www.thecse.ca.

Forward-Looking Information:

This press release may include forward-looking information within the meaning of Canadian securities legislation concerning the business of BioNeutra. Forward-looking information is based on certain key expectations and assumptions made by the management of BioNeutra. Although BioNeutra believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because BioNeutra can give no assurance that they will prove to be correct. Forward-looking statements contained in this press release are made as of the date of this press release. BioNeutra disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been and will not be registered under the United States Securities Act of 1933, as amended, or any applicable securities laws or any state of the United States and may not be offered or sold in the United States or to the account or benefit of a person in the United States absent an exemption from the registration requirements.

The CSE has not reviewed, approved or disapproved the content of this press release.

share thisEmail this to someoneShare on FacebookTweet about this on TwitterShare on LinkedIn

BioNeutra

9608 25 Avenue NW
Edmonton, Alberta T6N 1J4
Canada
Tel: 1.780.466.1481
Fax: 1.780.801.0036

©2017 BioNeutra